SCHEMBL21887878

SCHEMBL21887878

OC1(c2ccccc2)c2ccccc2Nc2ccccc21

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.48
MEN1 O00255 1/20 0.48
LMNA P02545 1/20 0.48
P2RX1 P51575 1/20 0.46
P2RX3 P56373 1/20 0.46
P2RX4 Q99571 1/20 0.46
P2RX7 Q99572 1/20 0.46
CYP2D6 P10635 1/20 0.42
TSHR P16473 1/20 0.42
POLB P06746 2/20 0.41
CASP6 P55212 1/20 0.41
CHRM2 P08172 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
KCNH2 Q12809 1/20 0.39
PDK2 Q15119 1/20 0.38
PDK4 Q16654 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 2/20 0.36
MAPT P10636 1/20 0.36
HTT P42858 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12165443 0.85 KMT2A (0.44) KMT2AMEN1LMNAP2RX1P2RX3
SCHEMBL12165439 0.85 KMT2A (0.44) KMT2AMEN1LMNAP2RX1P2RX3
SCHEMBL27889418 0.84 POLB (0.43) KMT2AMEN1LMNAP2RX1P2RX3
SCHEMBL18025761 0.84 KMT2A (0.66) KMT2AMEN1LMNAPOLBCASP6
SCHEMBL209276 0.84 KMT2A (0.66) KMT2AMEN1LMNAPOLBCASP6
SCHEMBL18552443 0.84 KMT2A (0.66) KMT2AMEN1LMNAPOLBCASP6
SCHEMBL31306897 0.84 KMT2A (0.66) KMT2AMEN1LMNAPOLBCASP6
SCHEMBL1758787 0.83 P2RX1 (0.53) LMNAP2RX1P2RX3P2RX4P2RX7
SCHEMBL813078 0.76 THRB (0.52) KMT2AMEN1LMNAP2RX1P2RX3
SCHEMBL29373003 0.76 LMNA (0.69) KMT2AMEN1LMNACYP2D6TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102675203-B Preparation method of acridine compound UNIV CHANGZHOU 2014-08-13 CN claimed
CN-102675203-A Preparation method of acridine compound UNIV CHANGZHOU 2012-09-19 CN claimed
US-11158814-B2 9,10-dihydro-acridine derivative, and preparation method and use thereof NINGBO LUMILAN ADVANCED MATERIALS CO., LTD (CN) 2021-10-26 US disclosed
WO-2020056859-A1 9,10-DIHYDROACRIDINE DERIVATIVE, PREPARATION METHOD THEREFOR AND USE THEREOF 宁波卢米蓝新材料有限公司 2020-03-26 WO disclosed
WO-2020056860-A1 9,10-DIHYDROACRIDINE DERIVATIVE, PREPARATION METHOD AND APPLICATION THEREOF 宁波卢米蓝新材料有限公司 2020-03-26 WO disclosed
US-20200091436-A1 9,10-DIHYDRO-ACRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF NINGBO LUMILAN ADVANCED MATERIALS CO., LTD. (CN) 2020-03-19 US disclosed
CN-102675203-B Preparation method of acridine compound UNIV CHANGZHOU 2014-08-13 CN disclosed
CN-102675203-A Preparation method of acridine compound UNIV CHANGZHOU 2012-09-19 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11158814-B2 9,10-dihydro-acridine derivative, and preparation method and use thereof GAPVD1, DHX9, DHRS9 KMT2A 3356/4885MEN1 4288/4885LMNA 535/4885
US-20200091436-A1 9,10-DIHYDRO-ACRIDINE DERIVATIVE, AND PREPARATION METHOD AND USE THEREOF DHODH, DHRS9, QDPR KMT2A 4294/4885MEN1 4830/4885LMNA 1105/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.